The latest new recruits bring expertise in many disciplines
In the last few months, new doctors from around the country have been arriving at Yale to work in cardiology, infectious diseases, ophthalmology and other areas of the practice. Their skills and expertise will mean even better care for our patients.
Emilio Gerardo Andrade, MD, is an assistant professor who is board-certified in anesthesiology. He has clinical interests in pain management and regional anesthesia. Dr. Andrade completed his medical degree at Universidad Evangelica De El Salvador, and his residency in anesthesiology at Yale-New Haven Hospital. He completed a fellowship in regional anesthesiology and acute perioperative pain management at Hospital for Special Surgery, Weill Cornell Medical College.
David Della-Giustina, MD, is board-certified in emergency medicine. In addition to his clinical activities, he will serve as chief of education and program director of the emergency medicine residency. Dr. Della-Giustina has interests in emergency orthopaedics, ultrasound and wilderness medicine. After finishing his bachelor’s degree at United States Military Academy, he completed his medical degree at Uniformed Services University, and both his emergency medicine residency and ultrasound fellowship at Madigan Army Medical Center. Dr. Della-Giustina has joined the Yale faculty after retiring from the U.S. Army as a colonel with 29 years of service and multiple combat tours in Iraq and Afghanistan.
AIDS Care Program
E. Jennifer Edelman, MD, MHS, is an assistant professor of medicine in the section of general medicine. She has clinical interests in general medicine, HIV medicine and substance abuse, and sees patients at the Nathan Smith Clinic. Dr. Edelman completed her medical degree at Columbia University, her residency and chief residency in internal medicine at Yale-New Haven Hospital, and her masters of health science research at Yale University. She is certified through the American Academy of HIV Medicine as an HIV specialist.
Louis A. Chaptini, MD, is an assistant professor in digestive diseases who is board-certified in both internal medicine and gastroenterology. His clinical interests include colorectal cancer prevention, gastrointestinal bleeding and obesity. Dr. Chaptini completed his medical degree at St. Joseph University in Beirut, and his internal medicine residency and gastroenterology fellowship at Cooper University Hospital /University of Medicine and Dentistry, New Jersey.
Terri Lynn Parker, MD, is an assistant professor in the Hematology Program at the Yale Cancer Center. She has board certifications in internal medicine and hospice & palliative medicine, is board-eligible in hematology and medical oncology. She has clinical interests in benign and malignant hematology, as well as hospice and palliative medicine. Dr. Parker completed her medical degree at St. George’s University School of Medicine Grenada, and her internal medicine residency, and hospice and palliative medicine fellowship at University of Connecticut Health Center. She then completed a fellowship in hematology and medical oncology at Yale School of Medicine.
Medical OncologySarah Beth Goldberg, MD, MPH, is an assistant professor in medical oncology who is board-certified in internal medicine, and board-eligible in medical oncology. She has clinical interests in lung cancer, personalized medicine and thoracic oncology. Dr. Goldberg completed her medical degree at Mount Sinai School of Medicine and her master’s in public health at Harvard School of Public Health. She was an internal medicine resident at Massachusetts General Hospital and a fellow at the Dana-Farber Cancer Institute and Massachusetts General Hospital.
Joseph Paul Eder, MD, is a Yale Cancer Center physician who is board-certified in internal medicine, hematology and medical oncology. His interests include the development of novel therapeutics including high dose chemotherapy, as well as the modulation/reversal of drug resistance, growth factors, vaccines, signal transduction pathway inhibitors, cell cycle inhibitors, and the therapeutic use of antiangiogenisis agents. He completed his medical degree, his internal medicine residency and a fellowship in medical oncology at Georgetown University School of Medicine, in addition to fellowships in oncology/hematology at Beth Israel Hospital and Dana-Farber Cancer Institute.
Daniel Petrylak, MD, is a professor at the Yale Cancer Center who is board-certified in medical oncology. His interests include genitourinary and prostate cancers, as well as clinical trials for men with prostate and bladder cancer. Dr. Petrylak completed his medical degree at Case Western University School of Medicine. He completed his internal medicine residency at Albert Einstein College of Medicine and his fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center.
Martin Alexander Kriegel, MD, PhD, is an assistant professor of immunobiology and rheumatology, who is board-certified in internal medicine and rheumatology. He has clinical interests in systemic autoimmune diseases including antiphospholipid syndrome, systemic lupus erythematosus, vasculitis and myositis. Dr. Kriegel completed his medical and doctorate degrees at Friedrich-Alexander University of Erlangen-Nurnberg, Germany. He has a postdoctoral fellowship in immunobiology from Yale School of Medicine. He completed his residency at Beth Israel Deaconess Medical Center and a fellowship in rheumatology at Brigham and Women’s Hospital.
Jason L. Gerrard, MD, PhD, is an assistant professor in neurosurgery who is board-eligible in neurological surgery. He has clinical interests in epilepsy, movement disorders, including Parkinson's disease, essential tremor and spasticity, trigeminal neuralgia, and brain tumors. In addition, he serves as the section head for neurotrauma and neurointensive monitoring. Dr. Gerrard also conducts research into the neurophysiological mechanisms of epilepsy and movement disorders. Dr. Gerrard completed his medical degree at University of Arizona, his residency in neurosurgery at the Massachusetts General Hospital and his fellowship in epilepsy surgery at Yale School of Medicine.
Rachel Fortune, MD, is an instructor in pediatrics who is board-certified in pediatrics and board-eligible in adolescent medicine. She has clinical interests in contraception, eating disorders, gynecology and mental health, and will have consultation clinics in those areas at both the Long Wharf and Norwalk pediatric specialty centers. Dr. Fortune completed her medical degree at Wake Forest University School of Medicine, her residency at Columbus Children’s Hospital and her fellowship in adolescent medicine at Children’s Hospital Colorado.
Shilpa Hattangadi, MD, is an assistant professor of pediatrics who is board-certified in both pediatrics and pediatric hematology and oncology. She has clinical interests in anemia, aplastic anemia, bone marrow failure, benign hematology, cytopenias, epo-refractory anemias, leukemia and pancytopenia. Dr. Hattangadi completed her medical degree at Duke University Medical Center and her residency in pediatrics at Johns Hopkins Hospital. She was a hematology-oncology fellow at Boston Children’s Hospital/Dana Farber Cancer Center and a postdoctoral fellow at the Whitehead Institute for Biomedical Research, in the laboratory of Dr. Harvey Lodish.
Peter Steven Yoo, MD, is a board-certified surgeon who specializes in the transplantation of liver, kidney and pancreas in both adults and children. He has additional clinical interests in the treatment of liver tumors in children and adults, portal hypertension, minimally invasive techniques, management of immunosuppression and related infections, management of bile duct injuries and disorders, living donor transplantation, polycystic kidney disease, difficult dialysis access and organ donation. Dr. Yoo was an undergraduate at Dartmouth College, completed his medical degree at SUNY at Stony Brook, and served as intern, resident, and administrative chief resident in surgery at Yale-New Haven Hospital. He subsequently completed advanced fellowship training in abdominal organ transplantation at the Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia.